KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sarepta Therapeutics (SRPT) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Sarepta Therapeutics (SRPT) over the last 13 years, with Q3 2025 value amounting to 0.39.

  • Sarepta Therapeutics' Asset Utilization Ratio fell 1753.0% to 0.39 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.39, marking a year-over-year decrease of 1753.0%. This contributed to the annual value of 0.53 for FY2024, which is 3530.53% up from last year.
  • Per Sarepta Therapeutics' latest filing, its Asset Utilization Ratio stood at 0.39 for Q3 2025, which was down 1753.0% from 0.52 recorded in Q2 2025.
  • In the past 5 years, Sarepta Therapeutics' Asset Utilization Ratio ranged from a high of 0.52 in Q2 2025 and a low of 0.2 during Q1 2021
  • For the 5-year period, Sarepta Therapeutics' Asset Utilization Ratio averaged around 0.35, with its median value being 0.32 (2023).
  • In the last 5 years, Sarepta Therapeutics' Asset Utilization Ratio surged by 4068.14% in 2021 and then tumbled by 1753.0% in 2025.
  • Quarter analysis of 5 years shows Sarepta Therapeutics' Asset Utilization Ratio stood at 0.24 in 2021, then increased by 22.9% to 0.3 in 2022, then surged by 31.38% to 0.39 in 2023, then rose by 28.93% to 0.5 in 2024, then decreased by 23.42% to 0.39 in 2025.
  • Its Asset Utilization Ratio was 0.39 in Q3 2025, compared to 0.52 in Q2 2025 and 0.43 in Q1 2025.